Form 4: Labcorp Executive Megan D. Bailey Reports Stock Option and Restricted Stock Unit Grants

Megan D. Bailey, EVP, Pres, Central Labs & Intl of Labcorp Holdings Inc., reports the acquisition of stock options and restricted stock units.

Summary

• On February 11, 2025, Megan D. Bailey, an executive at Labcorp Holdings Inc., reported transactions involving the company's securities.
• Bailey acquired 3,700 non-qualified stock options with an exercise price of $245.14.
• These options vest in three equal annual installments starting on February 11, 2026, and expire on February 10, 2035.
• Bailey also acquired 1,210 restricted stock units (RSUs), each representing the right to receive one share of Labcorp Holdings Inc. common stock.
• These RSUs vest in three equal annual installments beginning on February 11, 2026.
• Following these transactions, Bailey directly owns 3,700 stock options and 7,256 restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating a stable and ongoing business operation. The sentiment is neutral to slightly positive as it suggests continued investment in key personnel.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the stock options and RSUs.

Industry Context

This filing is a routine disclosure of executive compensation in the form of stock options and restricted stock units, a common practice in publicly traded companies to incentivize management.

Comparison to Industry Standards

• Stock option and RSU grants are standard components of executive compensation packages in publicly traded companies, including those in the diagnostics and healthcare services industries.
• Companies like Quest Diagnostics (DGX) and Charles River Laboratories (CRL) also utilize similar equity-based compensation plans to align executive incentives with shareholder value.
• The vesting schedules and grant sizes are generally benchmarked against peer companies to ensure competitiveness and retention.

Stakeholder Impact

• The grant of equity-based compensation can positively impact shareholders by aligning management's interests with long-term value creation.
• Employees may view the executive compensation package as a sign of the company's commitment to its leadership team.

Key Dates

Keywords

stock options, restricted stock units, Form 4, insider trading, executive compensation, LABCORP HOLDINGS INC., Megan D. Bailey